CEN-Consultorios Especializados en Neurociencias
About CEN-Consultorios Especializados en Neurociencias
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Boehringer Ingelheim
3
Janssen Research & Development, LLC
3
ACADIA Pharmaceuticals Inc.
2
Hoffmann-La Roche
2
H. Lundbeck A/S
1
Janssen-Cilag International NV
1
Janssen-Cilag Ltd.
1
Clinical Trials at CEN-Consultorios Especializados en Neurociencias
During the past decade, CEN-Consultorios Especializados en Neurociencias conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 1 clinical trials were completed, i.e. on
average, 7.7% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 1 clinical trials were completed. i.e. 10%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Extension Study of Pimavanserin for the Adjunctive Treatment of Schizophrenia
2017-01-01
2024-03-01
Recruiting
500
Safety and Efficacy Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD)
2018-08-22
2022-11-28
Terminated
982
A Long-term Comparison of Esketamine Nasal Spray Versus Quetiapine Extended Release, Both in Combination With a Selective Serotonin Reuptake Inhibitor/Serotonin-Norepinephrine Reuptake Inhibitor, in Participants With Treatment Resistant Major Depressive Disorder
2020-08-21
2022-07-15
Completed
676
A Study to Evaluate the Safety, Tolerability, and Efficacy of Long-Term Gantenerumab Administration in Participants With Alzheimer's Disease (AD)
2021-02-01
2023-03-06
Terminated
1,379
Comparison of Vortioxetine and Desvenlafaxine in Adult Patients Suffering From Depression
2020-06-18
2022-02-04
Completed
605
Efficacy and Safety of Pimavanserin as Adjunctive Treatment for the Negative Symptoms of Schizophrenia
2020-08-05
2024-01-01
Recruiting
426
A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant Therapy
2020-09-15
2022-07-14
Terminated
212
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "CEN-Consultorios Especializados en Neurociencias" #1 sponsor was "Boehringer Ingelheim" with 3 trials, followed by "Janssen Research & Development, LLC" with 3 trials
sponsored, "ACADIA Pharmaceuticals Inc." with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored and "H. Lundbeck A/S"
with 2 trials sponsored. Other sponsors include -3 different institutions and
companies that sponsored additional 7 trials in total.
Clinical Trials Conditions at CEN-Consultorios Especializados en Neurociencias
According to Clinical.Site data, the most researched conditions in "CEN-Consultorios Especializados en Neurociencias" are
"Schizophrenia" (5 trials), "Depressive Disorder, Major" (4 trials), "Alzheimer Disease" (2 trials), "Borderline Personality Disorder" (1 trials) and "Major Depressive Disorder" (1 trials). Many other conditions were trialed in "CEN-Consultorios Especializados en Neurociencias" in a lesser frequency.
Clinical Trials Intervention Types at CEN-Consultorios Especializados en Neurociencias
Most popular intervention types in "CEN-Consultorios Especializados en Neurociencias" are "Drug" (13 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "Gantenerumab" (2 trials), "Pimavanserin" (2 trials), "SSRI/SNRI" (2 trials) and "Aticaprant" (1 trials). Other intervention names were less common.
Clinical Trials Genders at CEN-Consultorios Especializados en Neurociencias
The vast majority of trials in "CEN-Consultorios Especializados en Neurociencias" are
13 trials for "All" genders.
Clinical Trials Status at CEN-Consultorios Especializados en Neurociencias
Currently, there are NaN active trials in "CEN-Consultorios Especializados en Neurociencias".
undefined are not yet recruiting,
5 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in CEN-Consultorios Especializados en Neurociencias,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in CEN-Consultorios Especializados en Neurociencias, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 10 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 0 trials that are defined as “Not Applicable".